Quality control of immunological veterinary medicinal products in Europe

1Article 1 of the Pharmaceutical Law of 19/12/2014, Journal of Laws of the Republic of Poland 2015, 0, item 28, as amended. Article 1 of the Pharmaceutical Law of 19/12/2014 Journal of Laws of the Republic of Poland 2015 0, item 28, as amendedSearch in Google Scholar

2Article 118 of the Pharmaceutical Law of 06/09/2001, Journal of Laws of the Republic of Poland 2001, 126, item 1381, as amended. Article 118 of the Pharmaceutical Law of 06/09/2001 Journal of Laws of the Republic of Poland 2001 126, item 1381, as amendedSearch in Google Scholar

3Article 2 point 9 of the Pharmaceutical Law of 06/09/2001, Journal of Laws of the Republic of Poland 2001, 126, item 1381, as amended. Article 2 point 9 of the Pharmaceutical Law of 06/09/2001 Journal of Laws of the Republic of Poland 2001 126, item 1381, as amendedSearch in Google Scholar

4Article 81 of Directive 2001/82/EC, as amended by Directive 2004/28/EC, of the European Parliament and the Council. Article 81 of Directive 2001/82/EC as amended by Directive 2004/28/EC, of the European Parliament and the CouncilSearch in Google Scholar

5Article 82 of Directive 2001/82/EC, as amended by Directive 2004/28/EC, of the European Parliament and the Council. Article 82 of Directive 2001/82/EC as amended by Directive 2004/28/EC, of the European Parliament and the CouncilSearch in Google Scholar

6Chang Y., Brewer N.T., Rinas A.C., Schmitt K., Smith J.S.: Evaluating the impact of human papillomavirus vaccines. Vaccine 2009, 27, 4355–4362. doi:10.1016/j.vaccine.2009.03 .008. PMID 19515467. Chang Y. Brewer N.T. Rinas A.C. Schmitt K. Smith J.S. Evaluating the impact of human papillomavirus vaccines Vaccine 2009 27 4355 4362 doi10.1016/j.vaccine.2009.03.008 PMID 1951546719515467Open DOISearch in Google Scholar

7Council of Europe: Presentation of the EDQM and its activities. 2016. https://www.youtube.com/watch?v=YWN7BsUyipc Council of Europe: Presentation of the EDQM and its activities 2016 https://www.youtube.com/watch?v=YWN7BsUyipcSearch in Google Scholar

8Encyclopedia Britannica: Entry on vaccines. https://www.britannica.com/science/vaccine Encyclopedia Britannica: Entry on vaccines https://www.britannica.com/science/vaccineSearch in Google Scholar

9EudraVigilance – European database of reports on suspected adverse drug reactions: Medicines in the EU. http://www.adrreports.eu/en/medicines_in_EU.html EudraVigilance – European database of reports on suspected adverse drug reactions: Medicines in the EU http://www.adrreports.eu/en/medicines_in_EU.htmlSearch in Google Scholar

10European Directorate for the Quality of Medicines & HealthCare (EDQM): Institutional Brochure. https://www.edqm.eu/sites/default/files/institutional-brochure-edqm.pdf European Directorate for the Quality of Medicines & HealthCare (EDQM): Institutional Brochure https://www.edqm.eu/sites/default/files/institutional-brochure-edqm.pdfSearch in Google Scholar

11European Directorate for the Quality of Medicines & HealthCare (EDQM): Levels of collaboration within the General European OMCL Network (GEON). https://www.edqm.eu/en/Levels-of-Collaboration-within-the-OMCL-129.html European Directorate for the Quality of Medicines & HealthCare (EDQM): Levels of collaboration within the General European OMCL Network (GEON) https://www.edqm.eu/en/Levels-of-Collaboration-within-the-OMCL-129.htmlSearch in Google Scholar

12European Directorate for the Quality of Medicines & HealthCare (EDQM): Official website. https://www.edqm.eu/ European Directorate for the Quality of Medicines & HealthCare (EDQM): Official website https://www.edqm.eu/Search in Google Scholar

13European Medicines Agency: Official website. https://www.ema.europa.eu/ European Medicines Agency: Official website https://www.ema.europa.eu/Search in Google Scholar

14European Union: Website listing EU agencies. https://europa.eu/european-union/about-eu/agencies/ema_pl European Union: Website listing EU agencies https://europa.eu/european-union/about-eu/agencies/ema_plSearch in Google Scholar

15Fijałek Z.: Role of the National Medicines Institute in quality assurances and safety of medicinal products and medical devices. Przegl Med Uniw Rzeszowskiego i Narod Inst Lek w Warszawie 2010, 3, 259–270. Fijałek Z. Role of the National Medicines Institute in quality assurances and safety of medicinal products and medical devices Przegl Med Uniw Rzeszowskiego i Narod Inst Lek w Warszawie 2010 3 259 270Search in Google Scholar

16Fiore A.E., Bridges C.B., Cox N.J.: Seasonal influenza vaccines. Current Topics Microbiol Immunol 2009, 333, 43–82. doi:10.1007/978-3-540-92165-3_3. ISBN 978-3-540-92164-6. PMID 19768400. Fiore A.E. Bridges C.B. Cox N.J. Seasonal influenza vaccines Current Topics Microbiol Immunol 2009 333 43 82 doi10.1007/978-3-540-92165-3_3 ISBN 978-3-540-92164-6. PMID 1976840019768400Open DOISearch in Google Scholar

17Guo Y., Lei K., Tang L.: Neoantigen vaccine delivery for personalized anticancer immunotherapy. Front Immunol 2018, 9, 1–8. doi: 10.3389/fimmu.2018.01499. eCollection 2018. Guo Y. Lei K. Tang L. Neoantigen vaccine delivery for personalized anticancer immunotherapy Front Immunol 2018 9 1 8 doi 10.3389/fimmu.2018.01499 eCollection 2018603611430013560Open DOISearch in Google Scholar

18Kretzschmar E., Muckenfuss H., Pfleiderer M.: Official batch control of influenza vaccines: Is it still useful? Vaccine 2018, 36, 2364–2370. Kretzschmar E. Muckenfuss H. Pfleiderer M. Official batch control of influenza vaccines: Is it still useful? Vaccine 2018 36 2364 237010.1016/j.vaccine.2018.02.07829580639Search in Google Scholar

19Liesegang T.J.: Varicella zoster virus vaccines: effective, but concerns linger. Canadian J Ophthalmol 2009, 44, 379–384. doi:10.3129/i09-126. PMID 19606157. Liesegang T.J. Varicella zoster virus vaccines: effective, but concerns linger Canadian J Ophthalmol 2009 44 379 384 doi10.3129/i09-126 PMID 1960615719606157Open DOISearch in Google Scholar

20Markey K., Douglas-Bardsley A., Hockley J., Le Tallec D., Costanzo A.: Calibration of pertussis toxin BRP batch 1 in a standardised CHO cell-based clustering assay. Pharmeur Bio Sci Notes 2018, 112–123. Markey K. Douglas-Bardsley A. Hockley J. Le Tallec D. Costanzo A. Calibration of pertussis toxin BRP batch 1 in a standardised CHO cell-based clustering assay Pharmeur Bio Sci Notes 2018 112 123Search in Google Scholar

21Matejtschuk P., Duru C., Bristow A.F., Burns C.J., Cowper B., Daas A., Costanzo A.: Establishment of detection antibodies BRRs batch 5 for in vitro potency assay of hepatitis A vaccines by ELISA. Pharmeur Bio Sci Notes 2019, 11–26. Matejtschuk P. Duru C. Bristow A.F. Burns C.J. Cowper B. Daas A. Costanzo A. Establishment of detection antibodies BRRs batch 5 for in vitro potency assay of hepatitis A vaccines by ELISA Pharmeur Bio Sci Notes 2019 11 26Search in Google Scholar

22Medycyna Praktyczna: Klasyfikacja i skład szczepionek (Classification and composition of vaccines (in Polish)). https://www.mp.pl/pacjent/choroby-zakazne/szczepienia/158371,klasyfikacja-i-sklad-szczepionek Medycyna Praktyczna: Klasyfikacja i skład szczepionek (Classification and composition of vaccines (in Polish)) https://www.mp.pl/pacjent/choroby-zakazne/szczepienia/158371,klasyfikacja-i-sklad-szczepionekSearch in Google Scholar

23Morgeaux S., Koy A., Manniam I., Regourd E., Variot P., Milne C.: Establishment of detection antibodies BRRs batch 5 for in vitro potency assay of hepatitis A vaccines by ELISA. Pharmeur Bio Sci Notes 2019, 1–10. Morgeaux S. Koy A. Manniam I. Regourd E. Variot P. Milne C. Establishment of detection antibodies BRRs batch 5 for in vitro potency assay of hepatitis A vaccines by ELISA Pharmeur Bio Sci Notes 2019 1 10Search in Google Scholar

24Sass J., Becker K., Ludmann D., Pantazoglou E., Dewenter H., Thun S.: Intercoder reliability of mapping between pharmaceutical dose forms in the German Medication Plan and EDQM Standard Terms. Stud Health Technol Inform 2018, 247, 845–849. Sass J. Becker K. Ludmann D. Pantazoglou E. Dewenter H. Thun S. Intercoder reliability of mapping between pharmaceutical dose forms in the German Medication Plan and EDQM Standard Terms Stud Health Technol Inform 2018 247 845 849Search in Google Scholar

25United States Centers for Disease Control and Prevention: A CDC framework for preventing infectious diseases: Sustaining the Essentials and Innovating for the Future. https://www.cdc.gov/ddid/framework.html United States Centers for Disease Control and Prevention: A CDC framework for preventing infectious diseases: Sustaining the Essentials and Innovating for the Future https://www.cdc.gov/ddid/framework.htmlSearch in Google Scholar

26United States Department of Health and Human Services: Types of vaccines. https://www.vaccines.gov/basics/types/index.html United States Department of Health and Human Services: Types of vaccines https://www.vaccines.gov/basics/types/index.htmlSearch in Google Scholar

27Wanko R., Unkelbach U.: European network of official medicines control laboratories: international OMCL Working Group combating counterfeit and other illegal medicines. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2017, 60, 1221–1227. doi: 10.1007/s00103-017-2625-7. Wanko R. Unkelbach U. European network of official medicines control laboratories: international OMCL Working Group combating counterfeit and other illegal medicines Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2017 60 1221 1227 doi 10.1007/s00103-017-2625-728921172Open DOISearch in Google Scholar